Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients

Am J Transplant. 2021 Aug;21(8):2919-2921. doi: 10.1111/ajt.16702. Epub 2021 Jun 18.
No abstract available

Keywords: clinical research/practice; immunobiology; infection and infectious agents-viral; infectious disease; organ transplantation in general; vaccine.

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • Humans
  • Immunity, Cellular
  • RNA, Messenger
  • SARS-CoV-2*
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • Vaccines
  • BNT162 Vaccine